Genesys Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
6
- Investments
-
68
- Portfolio
-
13
- Exits
-
26
Genesys Capital General Information
Company Description
Founded in 2000, Genesys Capital is a venture capital firm based in Toronto, Canada. The firm seeks to invest in early-stage companies operating in the life sciences, biotechnology, pharmaceuticals, and medical technology sectors.
Business Details
Website
www.genesyscapital.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- 123 Front Street West
- Suite 1503
- Toronto, Ontario M5J 2M2
- Canada
Genesys Capital Investments (68)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Specific Biologics | 02-Nov-2026 | Later Stage VC | Other Healthcare Technology Systems | Pre-Clinical Trials | ||
| BIOS Genomics | 01-Sep-2026 | Decision/Risk Analysis | Startup | |||
| Enspire DBS Therapy | 13-Jan-2026 | Clinics/Outpatient Services | Pre-Clinical Trials | |||
| Antegrade Medical | 16-Oct-2025 | Surgical Devices | Startup | |||
| Feldan Therapeutics | 08-Aug-2024 | Drug Delivery | Clinical Trials - Phase 1 | |||
| FloPatch | 14-Mar-2024 | Monitoring Equipment | Generating Revenue | |||
| CryoStasis | 27-Jul-2023 | Medical Supplies | Generating Revenue | |||
| Veralox Therapeutics | 21-Jun-2023 | Drug Discovery | Generating Revenue | |||
| Inversago Pharma | 14-Oct-2022 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| Questat | 01-Jan-2022 | Early Stage VC | Other Healthcare Technology Systems | Generating Revenue |
Genesys Capital Exits (26)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Therapeutic Monitoring Systems | 01-Mar-2025 | Secondary Transaction - Private | |
| Inversago Pharma | 08-Sep-2023 | ||
| Idbydna | 04-Jun-2022 | ||
| Profound Medical | 21-Jul-2020 | ||
| Fairhaven Pharmaceuticals | 16-Jul-2020 | ||
| Fusion Pharmaceuticals | 26-Jun-2020 | ||
| ImpoPharma | 25-Jul-2018 | ||
| Aptinyx | 21-Jun-2018 | ||
| Naurex | 28-Aug-2015 | Merger/Acquisition | |
| Invitae | 12-Feb-2015 | IPO |
Genesys Capital Investments by Industry, Year, and Region
Genesys Capital Co-Investors (29)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| AQC Capital | 2 |
|
|
||
| Amgen Ventures |
|
|
|||
| Fonds de solidarite FTQ |
|
|
|||
| Hatteras Venture Partners |
|
|
|||
| Seido Capital |
|
|
Genesys Capital FAQs
-
What is Genesys Capital?
Founded in 2000, Genesys Capital is a venture capital firm based in Toronto, Canada.
-
When was Genesys Capital founded?
Genesys Capital was founded in 2000.
-
Where is Genesys Capital headquartered?
Genesys Capital is headquartered in Toronto, Canada.
-
What is Genesys Capital's total asset value?
Genesys Capital has around in total assets under management.
-
How many investments has Genesys Capital made?
Genesys Capital has made 68 investments.
-
What has Genesys Capital invested in?
Genesys Capital has made numerous investments in companies like Specific Biologics, BIOS Genomics, and Enspire DBS Therapy within the Healthcare Technology Systems, Decision/Risk Analysis, and Clinics/Outpatient Services industries.
-
What has Genesys Capital invested in recently?
Genesys Capital's latest investment was on 02-Nov-2026 in Specific Biologics, a company within the Healthcare Technology Systems industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process